PL2424523T3 - Podjęzykowy preparat aerozolowy zawierający dihydroartemizyninę - Google Patents

Podjęzykowy preparat aerozolowy zawierający dihydroartemizyninę

Info

Publication number
PL2424523T3
PL2424523T3 PL10715337T PL10715337T PL2424523T3 PL 2424523 T3 PL2424523 T3 PL 2424523T3 PL 10715337 T PL10715337 T PL 10715337T PL 10715337 T PL10715337 T PL 10715337T PL 2424523 T3 PL2424523 T3 PL 2424523T3
Authority
PL
Poland
Prior art keywords
preparation containing
aerosol preparation
dihydroartemisinin
sublingual aerosol
sublingual
Prior art date
Application number
PL10715337T
Other languages
English (en)
Polish (pl)
Inventor
Calvin John Ross
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Publication of PL2424523T3 publication Critical patent/PL2424523T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10715337T 2009-04-23 2010-04-23 Podjęzykowy preparat aerozolowy zawierający dihydroartemizyninę PL2424523T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
EP10715337A EP2424523B1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (1)

Publication Number Publication Date
PL2424523T3 true PL2424523T3 (pl) 2012-11-30

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10715337T PL2424523T3 (pl) 2009-04-23 2010-04-23 Podjęzykowy preparat aerozolowy zawierający dihydroartemizyninę

Country Status (23)

Country Link
US (4) US20120157518A1 (OSRAM)
EP (1) EP2424523B1 (OSRAM)
JP (1) JP5795760B2 (OSRAM)
CN (1) CN102395362B (OSRAM)
AU (1) AU2010240654C1 (OSRAM)
BR (1) BRPI1014887A8 (OSRAM)
CA (1) CA2756925A1 (OSRAM)
DK (1) DK2424523T3 (OSRAM)
ES (1) ES2390046T3 (OSRAM)
HR (1) HRP20120711T1 (OSRAM)
IL (1) IL215453A (OSRAM)
ME (1) ME02008B (OSRAM)
MX (1) MX2011010961A (OSRAM)
MY (1) MY155646A (OSRAM)
NZ (1) NZ595469A (OSRAM)
PL (1) PL2424523T3 (OSRAM)
PT (1) PT2424523E (OSRAM)
RS (1) RS52430B (OSRAM)
RU (1) RU2501550C2 (OSRAM)
SG (1) SG175162A1 (OSRAM)
SI (1) SI2424523T1 (OSRAM)
WO (1) WO2010122356A1 (OSRAM)
ZA (1) ZA201107088B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
JP2012524771A (ja) * 2009-04-23 2012-10-18 ロンドンファーマ リミテッド 中性油を含む舌下用の医薬組成物
EP2943193A2 (en) * 2013-01-14 2015-11-18 Health Clinics Limited Cancer drug and uses
WO2016083827A1 (en) 2014-11-27 2016-06-02 Cipla Limited Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
HUP0102851A3 (en) * 1998-07-14 2003-03-28 Bayer Ag Antiparasitic artemisinin derivatives (endoperoxides), process for their preparation and pharmaceutical compositions containing them
AU2002219472A1 (en) * 2001-01-02 2002-07-16 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
MXPA04011808A (es) * 2002-05-31 2005-09-12 Univ Mississippi Liberacion transmucosica de canabinoides.
RU2004139090A (ru) * 2002-06-06 2005-06-10 Юниверсити Оф Вашингтон (Us) Способы применения соединений, подобных артемизинину, для профилактики или задержки возникновения злокачественных опухолей
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
PT1933809E (pt) * 2005-10-11 2012-04-26 Yissum Res Dev Co Composições para administração por via nasal
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Also Published As

Publication number Publication date
NZ595469A (en) 2013-10-25
AU2010240654B2 (en) 2014-05-08
EP2424523A1 (en) 2012-03-07
SI2424523T1 (sl) 2012-11-30
CA2756925A1 (en) 2010-10-28
RU2501550C2 (ru) 2013-12-20
US20160022629A1 (en) 2016-01-28
IL215453A0 (en) 2011-12-29
SG175162A1 (en) 2011-11-28
HK1164140A1 (en) 2012-09-21
MY155646A (en) 2015-11-13
AU2010240654C1 (en) 2014-08-14
CN102395362B (zh) 2014-07-02
CN102395362A (zh) 2012-03-28
US20120157518A1 (en) 2012-06-21
AU2010240654A1 (en) 2011-10-20
HRP20120711T1 (hr) 2012-10-31
JP5795760B2 (ja) 2015-10-14
WO2010122356A1 (en) 2010-10-28
BRPI1014887A8 (pt) 2019-02-12
US20170368023A1 (en) 2017-12-28
BRPI1014887A2 (pt) 2016-04-19
RU2011139637A (ru) 2013-05-27
US20190142737A1 (en) 2019-05-16
DK2424523T3 (da) 2012-09-24
IL215453A (en) 2014-11-30
EP2424523B1 (en) 2012-06-27
MX2011010961A (es) 2012-04-20
JP2012524772A (ja) 2012-10-18
ES2390046T3 (es) 2012-11-06
ZA201107088B (en) 2012-12-27
PT2424523E (pt) 2012-10-03
RS52430B (sr) 2013-02-28
ME02008B (me) 2013-02-28

Similar Documents

Publication Publication Date Title
EP2461683A4 (en) BICYCLIC ARYL SPHINGOSINE-1-PHOSPHATE ANALOG
HUE058021T2 (hu) Aeroszolgenerátor
DK2225988T3 (da) Dispenserhus
EP2498885A4 (en) TOY KREISEL
DK3320979T3 (da) Dispenser
UA21012S (uk) Іграшка
DK2515854T3 (da) Aerosolformulering for COPD
BRPI1012729A2 (pt) dispensador
EP2390021A4 (en) HOLLOW ELEMENT
IT1397007B1 (it) Dispenser
PL2424523T3 (pl) Podjęzykowy preparat aerozolowy zawierający dihydroartemizyninę
JP2009286769A5 (ja) 泡沫形成エアゾール組成物
FR2947248B1 (fr) Palette
EE00860U1 (et) Soolaaerosooli kllastamisseade
ES1072838Y (es) Posavaso
ITPG20080044A1 (it) Barriera aerosol dentale -rm5
FI8414U1 (fi) Pakkaus
FI8491U1 (fi) Pakkaus
UA19670S (uk) Упакування
TH102643B (th) บรรจุภัณฑ์
UA20065S (uk) Упаковка
UA20495S (uk) Пакування
UA19329S (uk) Упаковка
UA19599S (uk) Упакування
UA20051S (uk) Упаковка